Keywords: Roche, Avastin, glioblastoma, ECCO/ESMO, Research

Roche’s Avastin could play an important role for patients with the most aggressive form of brain cancer

Article | 22 September 2009

Print This

Swiss drug major Roche reveals that an analysis of the Phase II BRAIN study of Avastin (bevacizumab) alone or in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in